High resolution navigated three-dimensional T1-weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 tesla

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 4, 2012, Pages 890-899

  Nagle, Scott K ^a,b   Busse, Reed F ^c   Brau, Anja C ^c   Brittain, Jean H ^c   Frydrychowicz, Alex ^d   Iwadate, Yuji ^e   Reeder, Scott B ^a,b,f  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c GE HEALTHCARE   (United States)

^d UNIVERSITY OF LÜBECK   (Germany)

^e GE HealthCare Japan   (Japan)

^f University of Wisconsin Madison   (United States)

Author keywords

gadoxetic acid; liver imaging; magnetic resonance; navigator; optimization; primary sclerosing cholangitis

Indexed keywords

GADOXETIC ACID;

ADULT; ARTICLE; BILIARY EXCRETION; BILIARY TRACT DISEASE; BREATHING; CONTROLLED STUDY; FEMALE; HEPATOBILIARY RADIOGRAPHY; HEPATOBILIARY SYSTEM; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; LIVER FUNCTION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ADULT; ALGORITHMS; BILE DUCTS, INTRAHEPATIC; BREATH HOLDING; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866349186     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23713     Document Type: Article

References (33)

1. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212: 876-884. (Pubitemid 29410996)
2. Spinazzi A, Lorusso V, Pirovano G, Kirchin M,. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999; 6: 282-291. (Pubitemid 32673373)
3. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-792.
4. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18: 457-467. (Pubitemid 351248177)
5. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237: 89-98. (Pubitemid 41346150)
6. Grazioli L, Morana G, Kirchin MA, Schneider G,. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005; 236: 166-177. (Pubitemid 40853309)
7. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO,. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008; 43: 504-511.
8. Jung G, Breuer J, Poll LW, et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47: 15-23. (Pubitemid 43177525)
9. Kim JI, Lee JM, Choi JY, et al. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol 2008; 43: 202-210. (Pubitemid 351643147)
10. Akpinar E, Turkbey B, Karcaaltincaba M, et al. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis. J Magn Reson Imaging 2009; 30: 578-585.
11. Gupta RT, Brady CM, Lotz J, Boll DT, Merkle EM,. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. AJR Am J Roentgenol 2010; 195: 405-413.
12. Frydrychowicz A, Lubner MG, Brown JJ, et al. Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 2012; 35: 492-511.
13. McKenzie CA, Lim D, Ransil BJ, et al. Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility. Radiology 2004; 230: 589-594. (Pubitemid 38133827)
14. Dahlstrom N, Persson A, Albiin N, Smedby O, Brismar TB,. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 2007; 48: 362-368. (Pubitemid 46633865)
15. Asbach P, Warmuth C, Stemmer A, et al. High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol 2008; 43: 809-815.
16. Runge VM,. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr 1998; 22: 643-650. (Pubitemid 28433803)
17. Frydrychowicz A, Nagle SK, D'souza SL, Vigen KK, Reeder SB,. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 2011; 34: 585-594.
18. Dietrich O, Raya JG, Reeder SB, Ingrisch M, Reiser MF, Schoenberg SO,. Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging 2008; 26: 754-762.
19. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199: 177-183. (Pubitemid 26098637)
20. Nagle SK, Busse RF, Brau AC, et al. High-resolution free-breathing 3D T1 weighted hepatobiliary imaging optimized for Gd-EOB-DTPA. In: Proceedings of the 18th Annual Meeting of ISMRM, Honolulu, 2009. (abstract 2076).
21. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR,. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002; 9: 1322-1325. (Pubitemid 35265403)
22. Carlos RC, Hussain HK, Song JH, Francis IR,. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 2002; 179: 87-92. (Pubitemid 34694816)
23. Kawel N, Seifert B, Luetolf M, Boehm T,. Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. AJR Am J Roentgenol 2009; 192: 1324-1329.
24. Lee MS, Lee JY, Kim SH, et al. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI. J Magn Reson Imaging 2011; 33: 149-159.
25. Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N,. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 2009; 50: 709-715.
26. Motosugi U, Ichikawa T, Sano K, et al. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 2011; 46: 141-145.
27. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724. (Pubitemid 41546838)
28. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE,. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 1999; 290: 153-157. (Pubitemid 29302315)
29. Takao H, Akai H, Tajima T, et al. MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 2011; 77: 325-329.
30. Jedynak AR, Kelcz F, Frydrychowicz A, Nagle SK, Reeder SB,. Clinical experience with gadoxetate-enhanced T1 weighted hepatobiliary imaging in primary sclerosing cholangitis. In: Proceedings of the 19th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. (abstract 2620).
31. Brau AC, Beatty PJ, Skare S, Bammer R,. Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods. Magn Reson Med 2008; 59: 382-395. (Pubitemid 351220102)
32. Lum DP, Busse RF, Francois CJ, et al. Increased volume of coverage for abdominal contrast-enhanced MR angiography with two-dimensional autocalibrating parallel imaging: initial experience at 3.0 Tesla. J Magn Reson Imaging 2009; 30: 1093-1100.
33. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 2005; 54: 748-754. (Pubitemid 41233774)